410 related articles for article (PubMed ID: 25704811)
1. Targeting vascular pericytes in hypoxic tumors increases lung metastasis via angiopoietin-2.
Keskin D; Kim J; Cooke VG; Wu CC; Sugimoto H; Gu C; De Palma M; Kalluri R; LeBleu VS
Cell Rep; 2015 Feb; 10(7):1066-81. PubMed ID: 25704811
[TBL] [Abstract][Full Text] [Related]
2. Targeting PDGF-mediated recruitment of pericytes blocks vascular mimicry and tumor growth.
Thijssen VL; Paulis YW; Nowak-Sliwinska P; Deumelandt KL; Hosaka K; Soetekouw PM; Cimpean AM; Raica M; Pauwels P; van den Oord JJ; Tjan-Heijnen VC; Hendrix MJ; Heldin CH; Cao Y; Griffioen AW
J Pathol; 2018 Dec; 246(4):447-458. PubMed ID: 30101525
[TBL] [Abstract][Full Text] [Related]
3. Combined inhibition of VEGF and PDGF signaling enforces tumor vessel regression by interfering with pericyte-mediated endothelial cell survival mechanisms.
Erber R; Thurnher A; Katsen AD; Groth G; Kerger H; Hammes HP; Menger MD; Ullrich A; Vajkoczy P
FASEB J; 2004 Feb; 18(2):338-40. PubMed ID: 14657001
[TBL] [Abstract][Full Text] [Related]
4. Pericyte depletion results in hypoxia-associated epithelial-to-mesenchymal transition and metastasis mediated by met signaling pathway.
Cooke VG; LeBleu VS; Keskin D; Khan Z; O'Connell JT; Teng Y; Duncan MB; Xie L; Maeda G; Vong S; Sugimoto H; Rocha RM; Damascena A; Brentani RR; Kalluri R
Cancer Cell; 2012 Jan; 21(1):66-81. PubMed ID: 22264789
[TBL] [Abstract][Full Text] [Related]
5. PDGFR-β inhibitor slows tumor growth but increases metastasis in combined radiotherapy and Endostar therapy.
Yin L; He J; Xue J; Na F; Tong R; Wang J; Gao H; Tang F; Mo X; Deng L; Lu Y
Biomed Pharmacother; 2018 Mar; 99():615-621. PubMed ID: 29653486
[TBL] [Abstract][Full Text] [Related]
6. Connection of pericyte-angiopoietin-Tie-2 system in diabetic retinopathy: friend or foe?
Cai J; Ruan Q; Chen ZJ; Han S
Future Med Chem; 2012 Nov; 4(17):2163-76. PubMed ID: 23190105
[TBL] [Abstract][Full Text] [Related]
7. Identification of a subset of pericytes that respond to combination therapy targeting PDGF and VEGF signaling.
Hasumi Y; Kłosowska-Wardega A; Furuhashi M; Ostman A; Heldin CH; Hellberg C
Int J Cancer; 2007 Dec; 121(12):2606-14. PubMed ID: 17691110
[TBL] [Abstract][Full Text] [Related]
8. Contrasting actions of selective inhibitors of angiopoietin-1 and angiopoietin-2 on the normalization of tumor blood vessels.
Falcón BL; Hashizume H; Koumoutsakos P; Chou J; Bready JV; Coxon A; Oliner JD; McDonald DM
Am J Pathol; 2009 Nov; 175(5):2159-70. PubMed ID: 19815705
[TBL] [Abstract][Full Text] [Related]
9. Selective eradication of tumor vascular pericytes by peptide-conjugated nanoparticles for antiangiogenic therapy of melanoma lung metastasis.
Guan YY; Luan X; Xu JR; Liu YR; Lu Q; Wang C; Liu HJ; Gao YG; Chen HZ; Fang C
Biomaterials; 2014 Mar; 35(9):3060-70. PubMed ID: 24393268
[TBL] [Abstract][Full Text] [Related]
10. Pericyte Insulin Receptors Modulate Retinal Vascular Remodeling and Endothelial Angiopoietin Signaling.
Warmke N; Platt F; Bruns AF; Ozber CH; Haywood NJ; Abudushalamu Y; Slater C; Palin V; Sukumar P; Wheatcroft SB; Yuldasheva NY; Kearney MT; Griffin KJ; Cubbon RM
Endocrinology; 2021 Nov; 162(11):. PubMed ID: 34460911
[TBL] [Abstract][Full Text] [Related]
11. Impaired pericyte recruitment and abnormal retinal angiogenesis as a result of angiopoietin-2 overexpression.
Feng Y; vom Hagen F; Pfister F; Djokic S; Hoffmann S; Back W; Wagner P; Lin J; Deutsch U; Hammes HP
Thromb Haemost; 2007 Jan; 97(1):99-108. PubMed ID: 17200776
[TBL] [Abstract][Full Text] [Related]
12. Effects of angiopoietin-2-blocking antibody on endothelial cell-cell junctions and lung metastasis.
Holopainen T; Saharinen P; D'Amico G; Lampinen A; Eklund L; Sormunen R; Anisimov A; Zarkada G; Lohela M; Heloterä H; Tammela T; Benjamin LE; Ylä-Herttuala S; Leow CC; Koh GY; Alitalo K
J Natl Cancer Inst; 2012 Mar; 104(6):461-75. PubMed ID: 22343031
[TBL] [Abstract][Full Text] [Related]
13. Sustained inflammation after pericyte depletion induces irreversible blood-retina barrier breakdown.
Ogura S; Kurata K; Hattori Y; Takase H; Ishiguro-Oonuma T; Hwang Y; Ahn S; Park I; Ikeda W; Kusuhara S; Fukushima Y; Nara H; Sakai H; Fujiwara T; Matsushita J; Ema M; Hirashima M; Minami T; Shibuya M; Takakura N; Kim P; Miyata T; Ogura Y; Uemura A
JCI Insight; 2017 Feb; 2(3):e90905. PubMed ID: 28194443
[TBL] [Abstract][Full Text] [Related]
14. TGF-β signaling promotes tumor vasculature by enhancing the pericyte-endothelium association.
Zonneville J; Safina A; Truskinovsky AM; Arteaga CL; Bakin AV
BMC Cancer; 2018 Jun; 18(1):670. PubMed ID: 29921235
[TBL] [Abstract][Full Text] [Related]
15. The EGFR inhibitor gefitinib suppresses recruitment of pericytes and bone marrow-derived perivascular cells into tumor vessels.
Iivanainen E; Lauttia S; Zhang N; Tvorogov D; Kulmala J; Grenman R; Salven P; Elenius K
Microvasc Res; 2009 Dec; 78(3):278-85. PubMed ID: 19596357
[TBL] [Abstract][Full Text] [Related]
16. Plastic roles of pericytes in the blood-retinal barrier.
Park DY; Lee J; Kim J; Kim K; Hong S; Han S; Kubota Y; Augustin HG; Ding L; Kim JW; Kim H; He Y; Adams RH; Koh GY
Nat Commun; 2017 May; 8():15296. PubMed ID: 28508859
[TBL] [Abstract][Full Text] [Related]
17. Multitargeting strategy using lenvatinib and golvatinib: maximizing anti-angiogenesis activity in a preclinical cancer model.
Nakazawa Y; Kawano S; Matsui J; Funahashi Y; Tohyama O; Muto H; Nakagawa T; Matsushima T
Cancer Sci; 2015 Feb; 106(2):201-7. PubMed ID: 25458359
[TBL] [Abstract][Full Text] [Related]
18. R-Ras Deficiency in Pericytes Causes Frequent Microphthalmia and Perturbs Retinal Vascular Development.
Herrera JL; Komatsu M
J Vasc Res; 2021; 58(4):252-266. PubMed ID: 33873190
[TBL] [Abstract][Full Text] [Related]
19. A multitargeted, metronomic, and maximum-tolerated dose "chemo-switch" regimen is antiangiogenic, producing objective responses and survival benefit in a mouse model of cancer.
Pietras K; Hanahan D
J Clin Oncol; 2005 Feb; 23(5):939-52. PubMed ID: 15557593
[TBL] [Abstract][Full Text] [Related]
20. Angiopoietin 2 induces pericyte apoptosis via α3β1 integrin signaling in diabetic retinopathy.
Park SW; Yun JH; Kim JH; Kim KW; Cho CH; Kim JH
Diabetes; 2014 Sep; 63(9):3057-68. PubMed ID: 24722242
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
